2009
DOI: 10.1016/j.biochi.2008.09.006
|View full text |Cite
|
Sign up to set email alerts
|

Hypoglycaemic, antioxidative and nephroprotective effects of taurine in alloxan diabetic rabbits

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
58
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 102 publications
(62 citation statements)
references
References 67 publications
4
58
0
Order By: Relevance
“…Previous studies of Winiarska et al (2009) reported Tau-mediated, diminished NOX activity in the kidney cortex of alloxan diabetic rabbits. Tau-mediated NOX activation in other cell types might be underlying the widely recognized antioxidant action of this amino acid as cited in numerous reports (Huxtable 1992;Schuller-Levis and Park 2003;Oprescu et al 2007).…”
Section: Discussionmentioning
confidence: 84%
“…Previous studies of Winiarska et al (2009) reported Tau-mediated, diminished NOX activity in the kidney cortex of alloxan diabetic rabbits. Tau-mediated NOX activation in other cell types might be underlying the widely recognized antioxidant action of this amino acid as cited in numerous reports (Huxtable 1992;Schuller-Levis and Park 2003;Oprescu et al 2007).…”
Section: Discussionmentioning
confidence: 84%
“…-ATPase activity and reduced TNF-a as well as NO production in kidney during various toxin and drug-induced pathophysiological conditions (Das et al 2010c;Roy et al 2009;Manna et al 2009b). The anti-hyperglycemic and nephroprotective roles of taurine in diabetes have already been reported (Winiarska et al 2009;Das et al 2011a;Franconi et al 2006;Gavrovskaya et al 2008). Besides, very limited in vivo and in vitro studies have demonstrated that the protective effect of taurine on diabetic kidney is mediated via suppression of AGEs, TGFb and ROS (Winiarska et al 2009;Nandhini and Anuradha 2003;Higo et al 2008).…”
Section: Introductionmentioning
confidence: 97%
“…Kidney does not depend on insulin for glucose uptake; thus the increased plasma glucose levels in diabetes will also result in high intracellular levels of glucose and face severe and sustained hyperglycemia (Chandra et al 2002). Evidence suggests that hyperglycemia is associated with increased production of reactive oxygen species (ROS) and the resulting oxidative stress is thought to play a key role in the pathogenesis of this disorder (Winiarska et al 2009). The possible enzymatic and non-enzymatic sources of ROS in the diabetic kidney are autoxidation of glucose, transition metal-catalyzed Fenton reactions, advanced glycation end products (AGEs), polyol pathway flux, mitochondrial respiratory chain deficiencies, xanthine oxidase activity, peroxidases, nitric oxide synthase (NOS) and NAD(P)H oxidase (Forbes et al 2008).…”
Section: Introductionmentioning
confidence: 99%
“…21,22 Furthermore, administration of certain amino acids shown to attenuates DN in experimental animals. [23][24][25] Literature lucid with evidence showed that L-glutamine (LG) possesses potent antiulcer, antioxidant, anti-bacterial, cardioprotective, anticancer, hepatoprotective, and anti-apoptotic potential. [26][27][28][29] It has been reported that LG significantly attenuated cisplatin-induced genotoxicity.…”
Section: Introductionmentioning
confidence: 99%